Navigation Links
Drexel Biomedical Researchers Develop Device to Predict Diabetic Wound Healing
Date:5/26/2010

PHILADELPHIA, May 26 /PRNewswire-USNewswire/ -- Complex wounds affect more patients in the United States than heart attack and stroke combined. About 150,000 amputations a year result from complex wounds, while about 80,000 are attributed to diabetes and peripheral arterial disease. There are currently no established methods for early detection of wound healing, or for precise identification of healing progress.

A new device developed by researchers can change chronic wound management. Researchers Elisabeth S. Papazoglou, Ph.D., and Leonid Zubkov, Sc.D., of Drexel University's School of Biomedical Engineering, Science and Health Systems, and Michael S. Weingarten, M.D., MBA, FACS of the Drexel University College of Medicine, have developed a prototype device that measures the level of oxygenated and deoxygenated hemoglobin near a wound and compares it to a control/non-wound site of the same patient. Based on study results, the time course of oxygenated hemoglobin change was found to be a strong indicator of wound healing.

Diffuse Near-Infrared Spectroscopy allows tissue to be non-invasively analyzed by measuring its optical absorption and scattering coefficients. A "diagnostic window" exists at near infrared wavelengths (650 –900 nm), allowing determination of tissue optical properties at significant depths, because light is able to penetrate several centimeters into tissue due to low absorption of hemoglobin.  The absorption spectra of oxy-hemoglobin and deoxy-hemoglobin are distinct at near-infrared wavelengths, and with proper instrumentation the absolute concentrations of each can be determined.

The device prototype has been developed and tested over the course of several years. The device is controlled by software from a laptop computer and can move from patient to patient in a busy clinical setting. Measurements can be taken at any spot within or around the wound and take seconds to complete. Results are displayed on the computer screen almost instantly following the measurement. Improved prototypes are being designed. In its final stages the device will become more portable.

Advantages of the Drexel technology:

  • Fast quantitative method for characterizing diabetic and pressure ulcers.
  • Quantitative assessment of ischemic tissue in a broad variety of clinical applications.
  • Ability to predict wound healing due to therapy at least 50 percent earlier (four weeks as opposed to 8 weeks or more) compared to conventional methods.


'/>"/>
SOURCE Drexel University
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston University Biomedical Engineers Find Chink in Bacterias Armor
2. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
3. Saladax Biomedicals 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU
4. Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
5. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
6. NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute
7. OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
8. Subsidiary of Nova Biomedical Completes Acquisition of Assets of CCS Medicals Subsidiary, Sanvita, Inc.
9. Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research
10. Volcano Corporation Completes Acquisition of Lumen Biomedicals Xtract(TM) Thrombus Aspiration Catheter
11. Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical , ... company with their  2017 New Product Innovation Award for ... extensive primary and secondary medical device market research by Frost ... its first-to-market OTC, drug-free pain relief product, the AVACEN 100, ... to treating fibromyalgia widespread pain. ...
(Date:10/12/2017)... -- West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today announced that it will release third-quarter 2017 ... 26, 2017, and will follow with a conference call ... a.m. Eastern Time. To participate on the call, please ... is 94093362. A ...
(Date:10/11/2017)... 11, 2017  Caris Life Sciences ® , a ... promise of precision medicine, today announced that St. Jude ... Oncology Alliance™ (POA) as its 17 th member. ... Jude Crosson Cancer Institute will help develop standards of ... tumor profiling, making cancer treatment more precise and effective. ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
Breaking Medicine News(10 mins):